Löfberg H, Grubb A (1979). ”Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system”. Scandinavian Journal of Clinical and Laboratory Investigation 39 (7): sid. 619–626. doi:10.3109/00365517909108866. PMID 119302.
Simonsen O, Grubb A, Thysell H (1985). ”The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate”. Scandinavian Journal of Clinical and Laboratory Investigation 45 (2): sid. 97–101. doi:10.3109/00365518509160980. PMID 3923607.
Grubb A, Simonsen O, Sturfelt G et al. (1985). ”Serum concentration of cystatin C, factor D and beta2-microglobulin as a measure of the glomerular filtration rate”. Acta Med Scand 218 (5): sid. 499–503. doi:10.1111/j.0954-6820.1985.tb08880.x. PMID 3911736.
Janowski R, Kozak M, Jankowska E et al. (2001). ”Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nat Struct Biol 8 (4): sid. 316–320. doi:10.1038/86188. PMID 11276250.
Kolodziejczyk R, Michalska K, Hernandez-Santoyo, A et al. (2010). ”Crystal structure of human cystatin C stabilized against amyloid formation”. FEBS J 277 (7): sid. 1726–1737. doi:10.1111/j.1742-4658.2010.07596.x. PMID 20175878.
Dalboge H, Jensen EB, Töttrup H et al. (1989). ”High-level expression of active human cystatin C in E. coli”. Gene 79 (2): sid. 325–332. doi:10.1016/0378-1119(89)90214-x. PMID 2529167.
Barrett A, Davies ME, Grubb A (1984). ”The place of human g-trace (cystatin C) amongst the cysteine proteinase inhibitors”. Biochem Biophys Res Commun 120 (2): sid. 631-636. doi:10.1016/0006-291x(84)91302-0. PMID 6203523.
Björck L, Åkesson P, Bohus M et al. (1989). ”Bacterial growth blocked by a synthetic peptide based upon the structure of a human proteinase inhibitor”. Nature 337 (6205): sid. 385-386. doi:10.1038/337385a0. PMID 2643059.
Palsdottir A, Abrahamson M, Thorsteinsson L et al. (1988). ”Mutation in cystatin C gene causes hereditary brain hemorrhage”. Lancet 2 (8611): sid. 603-604. doi:10.1016/s0140-6736(88)90641-1. PMID 2900981.
Newman DJ, Thakkar H, Edwards RG et al. (1995). ”Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine”. Kidney Internat 47 (1): sid. 312-318. doi:10.1038/ki.1995.40. PMID 7731163.
Grubb A, Nyman U, Björk J et al. (2005). ”Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease (MDRD) prediction equation for adults and the Schwartz and the Counahan-Barratt Prediction Equations for Children”. Clin Chem 51 (8): sid. 1420-1431. doi:10.1373/clinchem.2005.051557. PMID 15961546.
Grubb A, Horio M, Hansson LO et al. (2014). ”Generation of a new cystatin C-based estimating equation for glomerular filtration rate using seven assays standardized to the international calibrator”. Clin Chem 60 (7): sid. 974-986. doi:10.1373/clinchem.2013.220707. PMID 24829272.
Grubb A, Blirup-Jensen S, Lindström V, Schmidt C, Althaus H, Zegers I, IFCC Working Group on standardisation of cystatin C (WG-SCC) (2010). ”First certified reference material for cystatin C in human serum ERM-DA471/IFCC”. Clin Chem Lab Med 48 (11): sid. 1619-1621. doi:10.1515/CCLM.2010.318. PMID 21034257.
Grubb A (2020). ”Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options”. Clinical Biochemistry 83: sid. 12–20. doi:10.1016/j.clinbiochem.2020.06.002. PMID 32544475.
Grubb, Anders O. (1974). Immunoglobulins and crossed immunoelectrophoresis. Malmö. Libris736946
nih.gov
ncbi.nlm.nih.gov
Löfberg H, Grubb A (1979). ”Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system”. Scandinavian Journal of Clinical and Laboratory Investigation 39 (7): sid. 619–626. doi:10.3109/00365517909108866. PMID 119302.
Simonsen O, Grubb A, Thysell H (1985). ”The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate”. Scandinavian Journal of Clinical and Laboratory Investigation 45 (2): sid. 97–101. doi:10.3109/00365518509160980. PMID 3923607.
Grubb A, Simonsen O, Sturfelt G et al. (1985). ”Serum concentration of cystatin C, factor D and beta2-microglobulin as a measure of the glomerular filtration rate”. Acta Med Scand 218 (5): sid. 499–503. doi:10.1111/j.0954-6820.1985.tb08880.x. PMID 3911736.
Janowski R, Kozak M, Jankowska E et al. (2001). ”Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nat Struct Biol 8 (4): sid. 316–320. doi:10.1038/86188. PMID 11276250.
Kolodziejczyk R, Michalska K, Hernandez-Santoyo, A et al. (2010). ”Crystal structure of human cystatin C stabilized against amyloid formation”. FEBS J 277 (7): sid. 1726–1737. doi:10.1111/j.1742-4658.2010.07596.x. PMID 20175878.
Dalboge H, Jensen EB, Töttrup H et al. (1989). ”High-level expression of active human cystatin C in E. coli”. Gene 79 (2): sid. 325–332. doi:10.1016/0378-1119(89)90214-x. PMID 2529167.
Barrett A, Davies ME, Grubb A (1984). ”The place of human g-trace (cystatin C) amongst the cysteine proteinase inhibitors”. Biochem Biophys Res Commun 120 (2): sid. 631-636. doi:10.1016/0006-291x(84)91302-0. PMID 6203523.
Abrahamson M, Ritonja A, Brown M et al. (1987). ”Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin”. J Biol Chem 262 (20): sid. 9688-9694. PMID 3496337.
Björck L, Åkesson P, Bohus M et al. (1989). ”Bacterial growth blocked by a synthetic peptide based upon the structure of a human proteinase inhibitor”. Nature 337 (6205): sid. 385-386. doi:10.1038/337385a0. PMID 2643059.
Palsdottir A, Abrahamson M, Thorsteinsson L et al. (1988). ”Mutation in cystatin C gene causes hereditary brain hemorrhage”. Lancet 2 (8611): sid. 603-604. doi:10.1016/s0140-6736(88)90641-1. PMID 2900981.
Kyhse-Andersen J, Schmidt C, Nordin G et al. (1994). ”Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate”. Clin Chem 40 (10): sid. 1921-1926. PMID 7923773.
Nilsson-Ehle P, Grubb A (1994). ”New markers for the determination of GFR: Iohexol clearance and cystatin C serum concentration”. Kidney Int Suppl 47: sid. 17-19. PMID 7869664.
Newman DJ, Thakkar H, Edwards RG et al. (1995). ”Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine”. Kidney Internat 47 (1): sid. 312-318. doi:10.1038/ki.1995.40. PMID 7731163.
Grubb A, Nyman U, Björk J et al. (2005). ”Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease (MDRD) prediction equation for adults and the Schwartz and the Counahan-Barratt Prediction Equations for Children”. Clin Chem 51 (8): sid. 1420-1431. doi:10.1373/clinchem.2005.051557. PMID 15961546.
Grubb A, Horio M, Hansson LO et al. (2014). ”Generation of a new cystatin C-based estimating equation for glomerular filtration rate using seven assays standardized to the international calibrator”. Clin Chem 60 (7): sid. 974-986. doi:10.1373/clinchem.2013.220707. PMID 24829272.
Grubb A, Blirup-Jensen S, Lindström V, Schmidt C, Althaus H, Zegers I, IFCC Working Group on standardisation of cystatin C (WG-SCC) (2010). ”First certified reference material for cystatin C in human serum ERM-DA471/IFCC”. Clin Chem Lab Med 48 (11): sid. 1619-1621. doi:10.1515/CCLM.2010.318. PMID 21034257.
Grubb A (2020). ”Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options”. Clinical Biochemistry 83: sid. 12–20. doi:10.1016/j.clinbiochem.2020.06.002. PMID 32544475.
